S&E Bio Achieves Landmark Approval for Korea's First Exosome-Based Therapy Clinical Trial S&E Bio has made history by receiving approval for the first exosome-based therapy clinical trial in Korea, focusing on stroke treatment.

S&E Bio Achieves Landmark Approval for Korea's First Exosome-Based Therapy Clinical Trial #South_Korea #Seoul #exosome_therapy #SE_bio #SNE-101